Article
Relevance of multidrug resistance in the age of targeted therapy.
Current opinion in drug discovery & development - 1 Mar 2009
Türk Dóra, Szakács Gergely
Abstract excerpt
Targeted drugs inhibit specific pathways that contribute to the malignant phenotype of cancer cells. The initial success of molecularly targeted therapies raised hope that newly developed agents would evade the general mechanisms of resistance that have reduced the efficacy of traditional anticancer drugs. In recent years, ATP-binding cassette (ABC) transporters related to multidrug resistance (MDR), such as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
